Related Experiment Video
Updated: Aug 5, 2026

07:29
Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model
Published on: September 27, 2024
Infrared Spectroscopy for Determining Bone Graft Healing and Readiness in Tissue Models
Summary
Visible near-infrared (VNIR) spectroscopy offers a noninvasive method to quantitatively assess bone graft (BG) healing. This technique accurately predicts healing stages, aiding in optimal dental implant timing.
Area of Science:
- Biomaterials science
- Spectroscopy
- Dental regenerative medicine
Background:
- Dental implant success depends on bone graft (BG) integration.
- Current radiographic methods offer limited quantitative assessment of BG maturation.
- Accurate assessment is crucial for determining optimal implant placement timing.
Purpose of the Study:
- To investigate visible near-infrared (VNIR) spectroscopy for quantitative assessment of intraoral bone graft healing.
- To evaluate VNIR spectroscopy's potential as a noninvasive tool for monitoring compositional changes during BG maturation.
- To correlate spectral data with progressive stages of bone graft healing in novel tissue models.
Main Methods:
- Developed six tissue models simulating progressive bone graft (BG) healing stages.
- Collected spectra using VNIR spectroscopy (ASD LabSpec4).
- Applied preprocessing, principal component analysis (PCA), and machine learning (LDA, KNN) for compositional analysis and stage classification.
Main Results:
- VNIR spectroscopy differentiated bone graft from native bone and detected spectral changes during graft maturation.
- Increased C-H absorbances correlated with advanced healing stages, resembling healthy bone spectra.
- Machine learning classification achieved 97% accuracy in predicting BG healing stages.
Conclusions:
- VNIR spectroscopy shows significant potential as a noninvasive, quantitative tool for monitoring intraoral bone graft healing.
- Identification of compositional markers (e.g., C-H absorbances) can guide optimal dental implant timing.
- Further pre-clinical validation is necessary to support clinical trials and enhance treatment planning.

